Originating as a research project at the University of Toronto, ChipCare
is bringing medical testing out of the lab and into the hands of patients worldwide with its portable handheld cell analyzer system. The integrated point-of-care and monitoring system provides state-of-the-art blood analysis at a fraction of the cost of the equivalent test performed in a routine medical laboratory. It also allows testing for different diseases with a single drop of blood and offers results in 10 to 15 minutes, giving ChipCare a significant competitive advantage over current methods.
Co-founded by PhD candidate James Dou, ChipCare aims to radically improve global health by addressing cost, time and ease-of-use challenges in both resource-rich and resource-limited environments. In 2012, the handheld cell analyzer system earned ChipCare recognition from Grand Challenges Canada and the team used the $100,000 grant to test its product in Mozambique—where roughly 16 per cent of the adult population is living with HIV—demonstrating its potential to revolutionize testing and treatment for HIV worldwide.
ChipCare received support under OCE’s SmartStart program and is now developing the product with follow-on funding from OCE’s Market Readiness program and other sources, such as MaRS Innovation.
Return on Innovation
- Potential for significant social impact by improving global health monitoring and HIV testing in developing countries
- Secured $925,000 in follow-on funding and is currently working towards a significant angel investment
OCE©2013 Last updated 10/2013